Skip to search formSkip to main contentSkip to account menu

Fentanyl 0.6 MG Oral Lozenge

Known as: FENTANYL CITRATE 600MCG LOZENGE [VA Product], FENTANYL CITRATE 600 ug ORAL LOZENGE, FENTANYL CITRATE 600MCG LOZENGE 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Chronic noncancer pain is often undertreated. AIMS To assess the efficacy of fentanyl transdermal therapeutic system… 
2009
2009
PURPOSE To evaluate the analgesic effect of 200 microg oral transmucosal fentanyl citrate during peripheral retinal scatter… 
2004
2004
BackgroundOral transmucosal fentanyl citrate (OTFC; ACTIQ) incorporates fentanyl into a lozenge allowing drug delivery through… 
2003
2003
It is unknown whether two smaller doses of oral transmucosal fentanyl citrate (OTFC) administered simultaneously are… 
2002
2002
Ninety (90) patients with chronic pain who were treated with a long-acting opioid were instructed on use of oral transmucosal… 
1999
1999
  • Sonja W. Chandler
  • 1999
  • Corpus ID: 38431130
Review
1998
Review
1998
The physiochemical characteristics of the potent synthetic opioid agonist fentanyl make it ideal for noninvasive transmucosal… 
1998
1998
Thirty min prior to anaesthetic induction for surgery, children aged 4–12 years old were given a 10 μg·kg−1 oral transmucosal…